Prognostic significance of grading (MIB-1 system) in patients with myxoid liposarcoma

13Citations
Citations of this article
12Readers
Mendeley users who have this article in their library.

Abstract

Aims: To determine the relation between clinical outcome and tumour grade defined by a MIB-1 (Ki-67) score based grading system. Method: The clinical and pathological features of 50 patients with myxoid liposarcoma were evaluated, and MIB-1 immunostaining was performed to grade these patients' tumours. Univariate and multivariate analyses were conducted to evaluate survival. Clinical follow up details were available for all patients (median, 46.5 months; range, 9-408). Results: Univariate analysis revealed that the tumour site (p < 0.05), round cell component content (p < 0.01), necrosis (p < 0.01), mitosis (p < 0.01), MIB-1 labelling index (p < 0.001), and tumour grade (p < 0.001) had a significant impact on overall survival. Multivariate analysis showed that, of the variables evaluated, the tumour grade defined by a MIB-1 score based grading system was the most significant adverse prognostic factor. Conclusion: Tumour grade determined by the grading system using the MIB-1 score (MIB-1 system) is a very strong prognostic factor in patients with myxoid liposarcoma.

Cite

CITATION STYLE

APA

Tateishi, U., Hasegawa, T., Beppu, Y., Kawai, A., & Moriyama, N. (2003). Prognostic significance of grading (MIB-1 system) in patients with myxoid liposarcoma. Journal of Clinical Pathology, 56(8), 579–582. https://doi.org/10.1136/jcp.56.8.579

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free